Table of Content

1 Report Overview
1.1 Binge Eating Disorder Drug Definition
1.2 Market by Type
1.2.1 Global Binge Eating Disorder Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Antidepressants
1.2.3 Anticonvulsants
1.2.4 Anti-obesity Medications
1.3 Market Segment by Application
1.3.1 Global Binge Eating Disorder Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Binge Eating Disorder Drug Sales
2.1 Global Binge Eating Disorder Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Binge Eating Disorder Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Binge Eating Disorder Drug Revenue by Region
2.3.1 Global Binge Eating Disorder Drug Revenue by Region (2018-2023)
2.3.2 Global Binge Eating Disorder Drug Revenue by Region (2024-2034)
2.4 Global Binge Eating Disorder Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Binge Eating Disorder Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Binge Eating Disorder Drug Sales Quantity by Region
2.6.1 Global Binge Eating Disorder Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Binge Eating Disorder Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Binge Eating Disorder Drug Sales Quantity by Manufacturers
3.1.1 Global Binge Eating Disorder Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Binge Eating Disorder Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Binge Eating Disorder Drug Sales in 2024
3.2 Global Binge Eating Disorder Drug Revenue by Manufacturers
3.2.1 Global Binge Eating Disorder Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Binge Eating Disorder Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Binge Eating Disorder Drug Revenue in 2024
3.3 Global Binge Eating Disorder Drug Sales Price by Manufacturers
3.4 Global Key Players of Binge Eating Disorder Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Binge Eating Disorder Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Binge Eating Disorder Drug, Product Offered and Application
3.8 Global Key Manufacturers of Binge Eating Disorder Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Binge Eating Disorder Drug Sales Quantity by Type
4.1.1 Global Binge Eating Disorder Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Binge Eating Disorder Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Binge Eating Disorder Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Binge Eating Disorder Drug Revenue by Type
4.2.1 Global Binge Eating Disorder Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Binge Eating Disorder Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Binge Eating Disorder Drug Revenue Market Share by Type (2018-2034)
4.3 Global Binge Eating Disorder Drug Price by Type
4.3.1 Global Binge Eating Disorder Drug Price by Type (2018-2023)
4.3.2 Global Binge Eating Disorder Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Binge Eating Disorder Drug Sales Quantity by Application
5.1.1 Global Binge Eating Disorder Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Binge Eating Disorder Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Binge Eating Disorder Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Binge Eating Disorder Drug Revenue by Application
5.2.1 Global Binge Eating Disorder Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Binge Eating Disorder Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Binge Eating Disorder Drug Revenue Market Share by Application (2018-2034)
5.3 Global Binge Eating Disorder Drug Price by Application
5.3.1 Global Binge Eating Disorder Drug Price by Application (2018-2023)
5.3.2 Global Binge Eating Disorder Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Binge Eating Disorder Drug Sales by Company
6.1.1 North America Binge Eating Disorder Drug Revenue by Company (2018-2023)
6.1.2 North America Binge Eating Disorder Drug Sales Quantity by Company (2018-2023)
6.2 North America Binge Eating Disorder Drug Market Size by Type
6.2.1 North America Binge Eating Disorder Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Binge Eating Disorder Drug Revenue by Type (2018-2034)
6.3 North America Binge Eating Disorder Drug Market Size by Application
6.3.1 North America Binge Eating Disorder Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Binge Eating Disorder Drug Revenue by Application (2018-2034)
6.4 North America Binge Eating Disorder Drug Market Size by Country
6.4.1 North America Binge Eating Disorder Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Binge Eating Disorder Drug Revenue by Country (2018-2034)
6.4.3 North America Binge Eating Disorder Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Binge Eating Disorder Drug Sales by Company
7.1.1 Europe Binge Eating Disorder Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Binge Eating Disorder Drug Revenue by Company (2018-2023)
7.2 Europe Binge Eating Disorder Drug Market Size by Type
7.2.1 Europe Binge Eating Disorder Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Binge Eating Disorder Drug Revenue by Type (2018-2034)
7.3 Europe Binge Eating Disorder Drug Market Size by Application
7.3.1 Europe Binge Eating Disorder Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Binge Eating Disorder Drug Revenue by Application (2018-2034)
7.4 Europe Binge Eating Disorder Drug Market Size by Country
7.4.1 Europe Binge Eating Disorder Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Binge Eating Disorder Drug Revenue by Country (2018-2034)
7.4.3 Europe Binge Eating Disorder Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Binge Eating Disorder Drug Sales by Company
8.1.1 China Binge Eating Disorder Drug Sales Quantity by Company (2018-2023)
8.1.2 China Binge Eating Disorder Drug Revenue by Company (2018-2023)
8.2 China Binge Eating Disorder Drug Market Size by Type
8.2.1 China Binge Eating Disorder Drug Sales Quantity by Type (2018-2034)
8.2.2 China Binge Eating Disorder Drug Revenue by Type (2018-2034)
8.3 China Binge Eating Disorder Drug Market Size by Application
8.3.1 China Binge Eating Disorder Drug Sales Quantity by Application (2018-2034)
8.3.2 China Binge Eating Disorder Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Binge Eating Disorder Drug Sales by Company
9.1.1 APAC Binge Eating Disorder Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Binge Eating Disorder Drug Revenue by Company (2018-2023)
9.2 APAC Binge Eating Disorder Drug Market Size by Type
9.2.1 APAC Binge Eating Disorder Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Binge Eating Disorder Drug Revenue by Type (2018-2034)
9.3 APAC Binge Eating Disorder Drug Market Size by Application
9.3.1 APAC Binge Eating Disorder Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Binge Eating Disorder Drug Revenue by Application (2018-2034)
9.4 APAC Binge Eating Disorder Drug Market Size by Region
9.4.1 APAC Binge Eating Disorder Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Binge Eating Disorder Drug Revenue by Region (2018-2034)
9.4.3 APAC Binge Eating Disorder Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Binge Eating Disorder Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Binge Eating Disorder Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Binge Eating Disorder Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Binge Eating Disorder Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Binge Eating Disorder Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Roche Binge Eating Disorder Drug Products and Services
11.1.5 Roche Binge Eating Disorder Drug SWOT Analysis
11.1.6 Roche Recent Developments
11.2 Chronos Therapeutics
11.2.1 Chronos Therapeutics Company Information
11.2.2 Chronos Therapeutics Overview
11.2.3 Chronos Therapeutics Binge Eating Disorder Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Chronos Therapeutics Binge Eating Disorder Drug Products and Services
11.2.5 Chronos Therapeutics Binge Eating Disorder Drug SWOT Analysis
11.2.6 Chronos Therapeutics Recent Developments
11.3 Heptares
11.3.1 Heptares Company Information
11.3.2 Heptares Overview
11.3.3 Heptares Binge Eating Disorder Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Heptares Binge Eating Disorder Drug Products and Services
11.3.5 Heptares Binge Eating Disorder Drug SWOT Analysis
11.3.6 Heptares Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Binge Eating Disorder Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Novo Nordisk Binge Eating Disorder Drug Products and Services
11.4.5 Novo Nordisk Binge Eating Disorder Drug SWOT Analysis
11.4.6 Novo Nordisk Recent Developments
11.5 Omeros Corp
11.5.1 Omeros Corp Company Information
11.5.2 Omeros Corp Overview
11.5.3 Omeros Corp Binge Eating Disorder Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Omeros Corp Binge Eating Disorder Drug Products and Services
11.5.5 Omeros Corp Binge Eating Disorder Drug SWOT Analysis
11.5.6 Omeros Corp Recent Developments
11.6 Sunovion Pharmaceuticals
11.6.1 Sunovion Pharmaceuticals Company Information
11.6.2 Sunovion Pharmaceuticals Overview
11.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Sunovion Pharmaceuticals Binge Eating Disorder Drug Products and Services
11.6.5 Sunovion Pharmaceuticals Binge Eating Disorder Drug SWOT Analysis
11.6.6 Sunovion Pharmaceuticals Recent Developments
11.7 Opiant Pharmaceuticals
11.7.1 Opiant Pharmaceuticals Company Information
11.7.2 Opiant Pharmaceuticals Overview
11.7.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Opiant Pharmaceuticals Binge Eating Disorder Drug Products and Services
11.7.5 Opiant Pharmaceuticals Binge Eating Disorder Drug SWOT Analysis
11.7.6 Opiant Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Binge Eating Disorder Drug Value Chain Analysis
12.2 Binge Eating Disorder Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Binge Eating Disorder Drug Production Mode & Process
12.4 Binge Eating Disorder Drug Sales and Marketing
12.4.1 Binge Eating Disorder Drug Sales Channels
12.4.2 Binge Eating Disorder Drug Distributors
12.5 Binge Eating Disorder Drug Customers
13 Market Dynamics
13.1 Binge Eating Disorder Drug Industry Trends
13.2 Binge Eating Disorder Drug Market Drivers
13.3 Binge Eating Disorder Drug Market Challenges
13.4 Binge Eating Disorder Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Antidepressants
Table 3. Major Manufacturers of Anticonvulsants
Table 4. Major Manufacturers of Anti-obesity Medications
Table 5. Global Binge Eating Disorder Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Binge Eating Disorder Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Binge Eating Disorder Drug Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Binge Eating Disorder Drug Revenue Market Share by Region (2018-2023)
Table 9. Global Binge Eating Disorder Drug Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Binge Eating Disorder Drug Revenue Market Share by Region (2024-2034)
Table 11. Global Binge Eating Disorder Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 12. Global Binge Eating Disorder Drug Sales by Region (2018-2023) & (K Units)
Table 13. Global Binge Eating Disorder Drug Sales Market Share by Region (2018-2023)
Table 14. Global Binge Eating Disorder Drug Sales by Region (2024-2034) & (K Units)
Table 15. Global Binge Eating Disorder Drug Sales Market Share by Region (2024-2034)
Table 16. Global Binge Eating Disorder Drug Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 17. Global Binge Eating Disorder Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Binge Eating Disorder Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Binge Eating Disorder Drug Revenue Share by Manufacturers (2018-2023)
Table 20. Global Binge Eating Disorder Drug Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Key Players of Binge Eating Disorder Drug, Industry Ranking, 2021 VS 2024
Table 22. Global Binge Eating Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Binge Eating Disorder Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Binge Eating Disorder Drug as of 2024)
Table 24. Global Key Manufacturers of Binge Eating Disorder Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Binge Eating Disorder Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Binge Eating Disorder Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Binge Eating Disorder Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 29. Global Binge Eating Disorder Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Binge Eating Disorder Drug Sales Quantity Share by Type (2018-2023)
Table 31. Global Binge Eating Disorder Drug Sales Quantity Share by Type (2024-2034)
Table 32. Global Binge Eating Disorder Drug Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Binge Eating Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Binge Eating Disorder Drug Revenue Share by Type (2018-2023)
Table 35. Global Binge Eating Disorder Drug Revenue Share by Type (2024-2034)
Table 36. Binge Eating Disorder Drug Price by Type (2018-2023) & (USD/Unit)
Table 37. Global Binge Eating Disorder Drug Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global Binge Eating Disorder Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 39. Global Binge Eating Disorder Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Binge Eating Disorder Drug Sales Quantity Share by Application (2018-2023)
Table 41. Global Binge Eating Disorder Drug Sales Quantity Share by Application (2024-2034)
Table 42. Global Binge Eating Disorder Drug Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Binge Eating Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Binge Eating Disorder Drug Revenue Share by Application (2018-2023)
Table 45. Global Binge Eating Disorder Drug Revenue Share by Application (2024-2034)
Table 46. Binge Eating Disorder Drug Price by Application (2018-2023) & (USD/Unit)
Table 47. Global Binge Eating Disorder Drug Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America Binge Eating Disorder Drug Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Binge Eating Disorder Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 50. North America Binge Eating Disorder Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Binge Eating Disorder Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Binge Eating Disorder Drug Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Binge Eating Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Binge Eating Disorder Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 55. North America Binge Eating Disorder Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Binge Eating Disorder Drug Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Binge Eating Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Binge Eating Disorder Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Binge Eating Disorder Drug Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Binge Eating Disorder Drug Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Binge Eating Disorder Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 62. North America Binge Eating Disorder Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Binge Eating Disorder Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 64. Europe Binge Eating Disorder Drug Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Binge Eating Disorder Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 66. Europe Binge Eating Disorder Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Binge Eating Disorder Drug Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Binge Eating Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Binge Eating Disorder Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Europe Binge Eating Disorder Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Binge Eating Disorder Drug Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Binge Eating Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Binge Eating Disorder Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Binge Eating Disorder Drug Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Binge Eating Disorder Drug Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Binge Eating Disorder Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 77. Europe Binge Eating Disorder Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Binge Eating Disorder Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 79. China Binge Eating Disorder Drug Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Binge Eating Disorder Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 81. China Binge Eating Disorder Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Binge Eating Disorder Drug Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Binge Eating Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Binge Eating Disorder Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 85. China Binge Eating Disorder Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Binge Eating Disorder Drug Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Binge Eating Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Binge Eating Disorder Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 89. APAC Binge Eating Disorder Drug Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Binge Eating Disorder Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 91. APAC Binge Eating Disorder Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Binge Eating Disorder Drug Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Binge Eating Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Binge Eating Disorder Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 95. APAC Binge Eating Disorder Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Binge Eating Disorder Drug Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Binge Eating Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Binge Eating Disorder Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Binge Eating Disorder Drug Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Binge Eating Disorder Drug Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Binge Eating Disorder Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 102. APAC Binge Eating Disorder Drug Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Company (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 117. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Roche Company Information
Table 119. Roche Description and Overview
Table 120. Roche Binge Eating Disorder Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 121. Roche Binge Eating Disorder Drug Product and Services
Table 122. Roche Binge Eating Disorder Drug SWOT Analysis
Table 123. Roche Recent Developments
Table 124. Chronos Therapeutics Company Information
Table 125. Chronos Therapeutics Description and Overview
Table 126. Chronos Therapeutics Binge Eating Disorder Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 127. Chronos Therapeutics Binge Eating Disorder Drug Product and Services
Table 128. Chronos Therapeutics Binge Eating Disorder Drug SWOT Analysis
Table 129. Chronos Therapeutics Recent Developments
Table 130. Heptares Company Information
Table 131. Heptares Description and Overview
Table 132. Heptares Binge Eating Disorder Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 133. Heptares Binge Eating Disorder Drug Product and Services
Table 134. Heptares Binge Eating Disorder Drug SWOT Analysis
Table 135. Heptares Recent Developments
Table 136. Novo Nordisk Company Information
Table 137. Novo Nordisk Description and Overview
Table 138. Novo Nordisk Binge Eating Disorder Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 139. Novo Nordisk Binge Eating Disorder Drug Product and Services
Table 140. Novo Nordisk Binge Eating Disorder Drug SWOT Analysis
Table 141. Novo Nordisk Recent Developments
Table 142. Omeros Corp Company Information
Table 143. Omeros Corp Description and Overview
Table 144. Omeros Corp Binge Eating Disorder Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 145. Omeros Corp Binge Eating Disorder Drug Product and Services
Table 146. Omeros Corp Binge Eating Disorder Drug SWOT Analysis
Table 147. Omeros Corp Recent Developments
Table 148. Sunovion Pharmaceuticals Company Information
Table 149. Sunovion Pharmaceuticals Description and Overview
Table 150. Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 151. Sunovion Pharmaceuticals Binge Eating Disorder Drug Product and Services
Table 152. Sunovion Pharmaceuticals Binge Eating Disorder Drug SWOT Analysis
Table 153. Sunovion Pharmaceuticals Recent Developments
Table 154. Opiant Pharmaceuticals Company Information
Table 155. Opiant Pharmaceuticals Description and Overview
Table 156. Opiant Pharmaceuticals Binge Eating Disorder Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 157. Opiant Pharmaceuticals Binge Eating Disorder Drug Product and Services
Table 158. Opiant Pharmaceuticals Binge Eating Disorder Drug SWOT Analysis
Table 159. Opiant Pharmaceuticals Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Binge Eating Disorder Drug Distributors List
Table 163. Binge Eating Disorder Drug Customers List
Table 164. Binge Eating Disorder Drug Market Trends
Table 165. Binge Eating Disorder Drug Market Drivers
Table 166. Binge Eating Disorder Drug Market Challenges
Table 167. Binge Eating Disorder Drug Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Binge Eating Disorder Drug Product Picture
Figure 2. Global Binge Eating Disorder Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Binge Eating Disorder Drug Market Share by Type in 2024 & 2034
Figure 4. Antidepressants Product Picture
Figure 5. Anticonvulsants Product Picture
Figure 6. Anti-obesity Medications Product Picture
Figure 7. Global Binge Eating Disorder Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Binge Eating Disorder Drug Market Share by Application in 2024 & 2034
Figure 9. Retail Pharmacies
Figure 10. Hospital Pharmacies
Figure 11. Online Pharmacies
Figure 12. Binge Eating Disorder Drug Report Years Considered
Figure 13. Global Binge Eating Disorder Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Binge Eating Disorder Drug Revenue 2018-2034 (US$ Million)
Figure 15. Global Binge Eating Disorder Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Binge Eating Disorder Drug Sales Quantity 2018-2034 (K Units)
Figure 17. Global Binge Eating Disorder Drug Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Binge Eating Disorder Drug Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Binge Eating Disorder Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Binge Eating Disorder Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Binge Eating Disorder Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Binge Eating Disorder Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Binge Eating Disorder Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Binge Eating Disorder Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Binge Eating Disorder Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Binge Eating Disorder Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Binge Eating Disorder Drug Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Binge Eating Disorder Drug Revenue in 2024
Figure 31. Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Binge Eating Disorder Drug Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Binge Eating Disorder Drug Revenue Market Share by Type (2018-2034)
Figure 34. Global Binge Eating Disorder Drug Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Binge Eating Disorder Drug Revenue Market Share by Application (2018-2034)
Figure 36. North America Binge Eating Disorder Drug Revenue Market Share by Company in 2024
Figure 37. North America Binge Eating Disorder Drug Sales Quantity Market Share by Company in 2024
Figure 38. North America Binge Eating Disorder Drug Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Binge Eating Disorder Drug Revenue Market Share by Type (2018-2034)
Figure 40. North America Binge Eating Disorder Drug Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Binge Eating Disorder Drug Revenue Market Share by Application (2018-2034)
Figure 42. North America Binge Eating Disorder Drug Revenue Share by Country (2018-2034)
Figure 43. North America Binge Eating Disorder Drug Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Binge Eating Disorder Drug Sales Quantity Market Share by Company in 2024
Figure 47. Europe Binge Eating Disorder Drug Revenue Market Share by Company in 2024
Figure 48. Europe Binge Eating Disorder Drug Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Binge Eating Disorder Drug Revenue Market Share by Type (2018-2034)
Figure 50. Europe Binge Eating Disorder Drug Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Binge Eating Disorder Drug Revenue Market Share by Application (2018-2034)
Figure 52. Europe Binge Eating Disorder Drug Revenue Share by Country (2018-2034)
Figure 53. Europe Binge Eating Disorder Drug Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 55. France Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 59. China Binge Eating Disorder Drug Sales Quantity Market Share by Company in 2024
Figure 60. China Binge Eating Disorder Drug Revenue Market Share by Company in 2024
Figure 61. China Binge Eating Disorder Drug Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Binge Eating Disorder Drug Revenue Market Share by Type (2018-2034)
Figure 63. China Binge Eating Disorder Drug Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Binge Eating Disorder Drug Revenue Market Share by Application (2018-2034)
Figure 65. APAC Binge Eating Disorder Drug Sales Quantity Market Share by Company in 2024
Figure 66. APAC Binge Eating Disorder Drug Revenue Market Share by Company in 2024
Figure 67. APAC Binge Eating Disorder Drug Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Binge Eating Disorder Drug Revenue Market Share by Type (2018-2034)
Figure 69. APAC Binge Eating Disorder Drug Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Binge Eating Disorder Drug Revenue Market Share by Application (2018-2034)
Figure 71. APAC Binge Eating Disorder Drug Revenue Share by Region (2018-2034)
Figure 72. APAC Binge Eating Disorder Drug Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 77. India Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Binge Eating Disorder Drug Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Binge Eating Disorder Drug Revenue Share by Country (2018-2034)
Figure 86. Brazil Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Binge Eating Disorder Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Binge Eating Disorder Drug Value Chain
Figure 92. Binge Eating Disorder Drug Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed